In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium

International Journal of Antimicrobial Agents

Volumn 26, Issue 1, 2005, Pages 28-32

  De Logu, Alessandro ^a   Saddi, Manuela ^a   Onnis, Valentina ^a   Sanna, Clara ^a   Congiu, Cenzo ^a   Borgna, Rita ^a   Cocco, Maria Teresa ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Drug combinations; In vitro activity; Mycobacterium avium; Rifamycins; S Alkylisothiosemicarbazone derivatives

Indexed keywords

CLOFAZIMINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PROTEINASE INHIBITOR; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; SEMICARBAZONE DERIVATIVE;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CELL LINE; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; IC 50; LOW DRUG DOSE; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM AVIUM COMPLEX; RIFAMYCINS; THIOSEMICARBAZONES;

EID: 20744446480     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.03.005     Document Type: Article

References (26)

1. J.O. Falkinham Epidemiology of infection by nontuberculous mycobacteria Clin Microbiol Rev 9 1996 177 215
2. C.B. Inderlied, C.A. Kemper, and L.E. Bermudez The Mycobacterium avium complex Clin Microbiol Rev 6 1993 266 310
3. L.E. Bermudez, C.B. Inderlied, and P. Kolonoski Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium Antimicrob Agents Chemother 45 2001 217 222
4. E. Nuermberger, and J. Grosset Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections Eur J Clin Microbiol Infect Dis 23 2004 243 255
5. C.A. Benson, P.L. Williams, and D.L. Cohn Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: a randomized, double-bind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team J Infect Dis 181 2000 1289 1297
6. R.E. Chaisson, C.A. Benson, and M.P. Dube Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-bind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team Ann Intern Med 121 1994 905 911
7. L. Horgen, A. Jerome, and N. Rastogi Pulsed-exposure and postantibiotic leukocyte enhancement effects of amikacin, clarithromycin, clofazimine, and rifampin against intracellular Mycobacterium avium Antimicrob Agents Chemother 42 1998 3006 3008
8. J.D. Vaudaux, and Y. Guex-Crosier Rifabutin-induced cystoid macular oedema J Antimicrob Chemother 49 2002 421 422
9. M.M. Gaspar, S. Neves, and F. Portales Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection Antimicrob Agents Chemother 44 2000 2424 2430
10. D.C. Quenelle, G.A. Winchester, and J.K. Staas Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid Antimicrob Agents Chemother 45 2001 1637 1644
11. D.M. Yajko, C.A. Sanders, and J.J. Madej In vitro activities of rifabutin, azithromycin, ciprofloxacin, clarithromycin, ethambutol, and amikacin in combinations of two, three, and four drugs against Mycobacterium avium Antimicrob Agents Chemother 49 1996 743 749
12. L.E. Bermudez, P. Kolonoski, and M. Petrofsky Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease J Infect Dis 15 2003 1977 1980
13. G. Abate, T. Koivula, and S.E. Hoffner In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex Int J Tuberc Lung Dis 6 2002 933 935
14. L.E. Bermudez, R. Reynolds, and P. Kolonoski Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice Antimicrob Agents Chemother 47 2003 2685 2687
15. M.T. Cocco, C. Congiu, and V. Onnis Synthesis and antimycobacterial activity of new S-alkylisothiosemicarbazone derivatives Bioorg Med Chem 10 2002 501 506
16. K. Sato, T. Akaki, and H. Tomioka Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages J Antimicrob Chemother 41 1998 77 83
17. H. Tomioka, K. Sato, and T. Akaki Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex Antimicrob Agents Chemother 43 1999 3001 3004
18. F.C. Odds Synergy, antagonism, and what the chequerboard puts between them J Antimicrob Chemother 52 2003 1
19. A. De Logu, V. Onnis, and B. Saddi Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis J Antimicrob Chemother 49 2002 275 282
20. C.W. Stratton, and R.C. Cooksey Susceptibility tests: special tests A. Balows W.J. Hausler K.L. Herrmann Manual of clinical microbiology 1991 American Society for Microbiology Washington, DC
21. N. Düzgüneş, D. Flasher, and M.V. Reddy Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin Antimicrob Agents Chemother 40 1996 2618 2621
22. O. Yu-Kyoung, D.E. Nix, and R.M. Straubinger Formulation and efficacy of liposome-encapsulate antibiotics for therapy of intracellular Mycobacterium avium infection Antimicrob Agents Chemother 39 1995 2104 2111
23. C.G. Lange, I.J. Woolley, and R.H. Brodt Disseminated Mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated? Drugs 64 2004 679 692
24. S.D. Shafran, L.D. Mashinter, and P. Phillis Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy Ann Intern Med 137 2002 734 737
25. S. Houston, and A. Fanning Current and potential treatment of tuberculosis Drugs 48 1994 689 708
26. L.B. Heifets, P.J. Lindholm-Levy, and M. Flory Thiacetazone: in vitro activity against Mycobacterium avium and M. tuberculosis Tubercle 71 1990 287 291